Reata UK Limited

Active06786814 Private limited company
Incorporated
9 January 2009 (17 years)
Industry
Research and experimental development on biotechnology (72110)
Directors
Neil Raymond Sisak
Owned by
Biogen Inc.
Accounts type
Small
Region
South West
Address
Suite 2
Ground Floor
Templeback
10 Temple Back
Bristol
BS1 6FL

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
22 January 2027
Last conf. stmt
8 January 2026

Charges

Total
3
Outstanding
0
Part satisfied
0
Satisfied
3

Officers 3 active

Officer details are public data from the Companies House register.

Director · Appointed 14 July 2025
British
Born April 1982 (44)
Director · Appointed 18 October 2023
Australian
Born March 1975 (51)
Sisak, Neil Raymond
Director · Appointed 18 October 2023
Swiss
Born August 1971 (55)
Officer history (6 former)
14 July 2025
Resigned Martinez, Geronimo as Director
14 July 2025
Appointed Purwaha, Amit Singh as Director
18 October 2023
Resigned Soni, Manmeet as Director
18 October 2023
Appointed Martinez, Geronimo as Director
18 October 2023
Appointed Sisak, Neil Raymond as Director
18 October 2023
Appointed Bromley, Kylie Michele as Director
22 September 2020
Resigned Huff, James Warren as Director
14 November 2019
Appointed Soni, Manmeet as Director
13 November 2019
Resigned Wilson, Jason Douglas, Mr. as Director
20 December 2018
Resigned Radius Commercial Services Limited as Corporate Secretary
15 February 2014
Resigned Holland, Betty as Director
10 February 2012
Appointed Radius Commercial Services Limited as Corporate Secretary
28 January 2011
Appointed Holland, Betty as Director
28 January 2011
Appointed Huff, James Warren as Director
9 January 2009
Appointed Wilson, Jason Douglas, Mr. as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Biogen Inc.
Corporate entity · Notified 26 September 2023
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporation
Reg. no. 33-0112644
Former controllers (1)
26 September 2023
Ceased Reata Pharmaceuticals Inc — Owns 75–100% of shares

Financials

Balance sheet as at 31 December 2025 · small accounts

Cash
£474,422
Current Ratio
3.7x

Trend

Shareholder Funds
£0 £200k £400k 2024 2025 £349,057 £347,956
Balance sheet detail
20252024
Current Assets£475,191£505,861
Debtors£769£176,466
Cash£474,422£329,395
Creditors (< 1 year)£127,235£156,804
Net Current Assets£347,956£349,057
Shareholder Funds£347,956£349,057

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
10 September 2026Director's details changed

Other companies in this industry

By trade and location

New companies in Bristol →

Explore the largest companies

Largest companies in Bristol, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?